By
MikeH on
September 11, 2012
Standing in the corner of a dark room, my eyes took a few moments to adjust to the darkness.
Ten feet in front of me, my mom sat at an eye-testing device the size of an oven. Next to her, a doctor stared at a dimmed screen, with two boxes displayed — one had a close-up of my mom’s right eye showing the inside crosshairs and the other resembled a line graph of what an eye-based…
Read more »
By
MikeH on
August 16, 2012
Three extra lines on an eye chart.
That may not seem like much at first glance (!), but those lines represent a significant step forward in the treatment of a form of diabetic retinopathy known as diabetic macular edema (DME).
In groundbreaking news this week, the Food and Drug Administration cleared the first drug of its kind to treat DME for people with diabetes, called Lucentis from California-based Genentech.
The FDA noted that this drug…
Read more »
